-
Mashup Score: 9Tolebrutinib versus Teriflunomide in Multiple Sclerosis | NEJM - 1 hour(s) ago
Quick Take Video Summary from The New England Journal of Medicine — Tolebrutinib versus Teriflunomide in Multiple Sclerosis
Source: www.nejm.orgCategories: General Medicine NewsTweet
-
Mashup Score: 121
Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of heart-failure admission among high-risk patients. However, most patients with valvular heart disease, including those undergoing…
Source: www.nejm.orgCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 11
Nerandomilast (BI 1015550) is an orally administered preferential inhibitor of phosphodiesterase 4B with antifibrotic and immunomodulatory properties. Nerandomilast has been shown to slow the progr…
Source: www.nejm.orgCategories: General Medicine NewsTweet
-
Mashup Score: 67An Evidence-Based Approach to Covid-19 Vaccination | NEJM - 4 hour(s) ago
This article from the FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach to such recommendations.
Source: www.nejm.orgCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 24As-Needed Albuterol–Budesonide in Mild Asthma | NEJM - 4 hour(s) ago
As-needed use of albuterol–budesonide has been shown to result in a significantly lower risk of severe asthma exacerbation than as-needed use of albuterol alone among patients with moderate-to-seve…
Source: www.nejm.orgCategories: General Medicine NewsTweet
-
Mashup Score: 19An Evidence-Based Approach to Covid-19 Vaccination | NEJM - 5 hour(s) ago
This article from the FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach to such recommendations.
Source: www.nejm.orgCategories: General Medicine NewsTweet
-
Mashup Score: 67An Evidence-Based Approach to Covid-19 Vaccination | NEJM - 5 hour(s) ago
This article from the FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach to such recommendations.
Source: www.nejm.orgCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 18Treatment of Pyelonephritis | NEJM - 7 hour(s) ago
EFFECTIVE therapy for most bacterial infections has been developed since the advent of potent antimicrobial agents. Chronic pyelonephritis, however, has been notably refractory to permanent cure. A…
Source: www.nejm.orgCategories: General Medicine NewsTweet
-
Mashup Score: 3Smoldering Multiple Myeloma | NEJM - 23 hour(s) ago
MULTIPLE myeloma is characterized by an increase of abnormal plasma cells in the bone marrow and monoclonal protein in the serum, often with osteolytic bone lesions. Its course is progressive: anem…
Source: www.nejm.orgCategories: General Medicine NewsTweet
-
Mashup Score: 234Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis | NEJM - 23 hour(s) ago
Nerandomilast (BI 1015550) is an orally administered preferential inhibitor of phosphodiesterase 4B with antifibrotic and immunomodulatory effects. In a phase 2 trial involving patients with idiopa…
Source: www.nejm.orgCategories: General Medicine NewsTweet
Tolebrutinib is a BTK inhibitor that is being studied for the treatment of relapsing multiple sclerosis. Research findings from the GEMINI 1 and GEMINI 2 trials comparing tolebrutinib with teriflunomide are summarized in a new Quick Take video. https://t.co/kb7KTzJsjO https://t.co/1LbXH48PVm